These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2147398)

  • 21. Developments in immunization against hepatitis B.
    Zuckerman AJ
    Ann Ist Super Sanita; 1987; 24(2):285-91. PubMed ID: 2969206
    [No Abstract]   [Full Text] [Related]  

  • 22. Surgeons and hepatitis B.
    Gough MH; Ribeiro BF
    BMJ; 1991 Oct; 303(6807):925. PubMed ID: 1834292
    [No Abstract]   [Full Text] [Related]  

  • 23. [Preventive hepatitis B vaccination].
    Glathe H; Dürkop J; Rasch G
    Z Arztl Fortbild (Jena); 1990; 84(8):381-3. PubMed ID: 2143042
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatitis B vaccine].
    Saengsirinavin C
    J Dent Assoc Thai; 1986; 36(2):51-60. PubMed ID: 2947941
    [No Abstract]   [Full Text] [Related]  

  • 25. Hepatitis B virus vaccine breakthrough infection: surveillance of S gene mutants of HBV.
    Qin Y; Liao P
    Acta Virol; 2018; 62(2):115-121. PubMed ID: 29895151
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B vaccination.
    Fagan EA; Williams R
    Br J Clin Pract; 1987 Jan; 41(1):569-76. PubMed ID: 2959306
    [No Abstract]   [Full Text] [Related]  

  • 27. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries.
    Basuni AA; Butterworth L; Cooksley G; Locarnini S; Carman WF
    Vaccine; 2004 Jul; 22(21-22):2791-9. PubMed ID: 15246613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hepatitis B virus infections in pregnancy. Diagnosis and prevention of vertical transmission].
    Bernardinetti G; Paesano R; Martelli MC; Pachì A; Di Mambro G; Angeloni G
    Minerva Ginecol; 1986 May; 38(5):351-8. PubMed ID: 2942799
    [No Abstract]   [Full Text] [Related]  

  • 29. Hepatitis B vaccines.
    Zuckerman AJ
    Postgrad Med J; 1986; 62 Suppl 2():3-10. PubMed ID: 2959911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [H-B-VAX II hepatitis B vaccine (recombinant) produced at the MSD Research Laboratories. Description of the vaccine].
    Przegl Epidemiol; 1991; 45(1-2):3-10. PubMed ID: 1839076
    [No Abstract]   [Full Text] [Related]  

  • 31. Pathogenesis, diagnosis, prophylaxis, and management of hepatitis B virus infection.
    Cooper B
    Compr Ther; 1989 Jul; 15(7):9-15. PubMed ID: 2527714
    [No Abstract]   [Full Text] [Related]  

  • 32. Immunisation of children born to mothers positive for anti-HBe.
    Neal KR; Radford JM
    BMJ; 1992 May; 304(6839):1441. PubMed ID: 1385744
    [No Abstract]   [Full Text] [Related]  

  • 33. [The analysis of "a" dominant mutation of hepatitis B virus in community-based population of Shandong Province, China].
    Zhang L; Yan BY; Ji F; Li MS; Song LZ; Xu AQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Dec; 24(6):424-6. PubMed ID: 21604565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B vaccine.
    N Engl J Med; 1987 Jan; 316(1):47-9. PubMed ID: 2946954
    [No Abstract]   [Full Text] [Related]  

  • 35. Hepatitis B virus.
    Tiollais P; Buendia MA
    Sci Am; 1991 Apr; 264(4):116-23. PubMed ID: 1876818
    [No Abstract]   [Full Text] [Related]  

  • 36. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
    Tabor E
    J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.
    Ijaz S; Khulan J; Bissett SL; Ferns RB; Nymadawa P; Tedder RS
    J Med Virol; 2006 Dec; 78(12):1554-9. PubMed ID: 17063521
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunisation against hepatitis B among NHS staff in West Midlands Regional Health Authority.
    Baddick MR; Aw TC
    BMJ; 1989 Sep; 299(6699):607. PubMed ID: 2529937
    [No Abstract]   [Full Text] [Related]  

  • 39. Control of hepatitis B in Australia. The case for alternative strategies.
    Gust ID
    Med J Aust; 1992 Jun; 156(12):819-21. PubMed ID: 1534864
    [No Abstract]   [Full Text] [Related]  

  • 40. Recombinant yeast hepatitis B vaccine.
    Hilleman MR
    Dev Biol Stand; 1986; 63():57-62. PubMed ID: 3527821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.